Ampicillin Price Trend and Forecast

Ampicillin Regional Price Overview

Get the latest insights on price movement and trend analysis of Ampicillin meal in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Ampicillin Price Trend for the Q4 of 2024

In the fourth quarter of 2024, the global Ampicillin market witnessed a generally stable but slightly increasing price trend. Early in the quarter, the market was characterized by weak demand, particularly in regions like Asia, where sluggish consumption from key sectors limited market activity. This was compounded by rising freight costs, which affected supply chains and contributed to supply tightness. However, as the quarter progressed, prices began to rise due to improved demand in the pharmaceutical sector, especially in Europe and North America, as companies sought to replenish stockpiles in anticipation of potential supply disruptions. Logistical challenges, such as port congestion and rising shipping costs, continued to exert upward pressure on prices.
 

Ampicillin Price Chart

Please Login or Subscribe to Access the Ampicillin Price Chart Data
 

The European market, in particular, saw more significant price movements as companies adjusted their strategies to cope with supply chain difficulties and stockpiling efforts. Similarly, in North America, a strong recovery in consumer confidence contributed to increased buying activity, which further supported price increases in the later months.

Analyst Insight

According to Procurement Resource, the Ampicillin market is expected to remain on an upward trajectory into 2025, influenced by continued supply chain disruptions, logistical challenges, and stable demand from the pharmaceutical industry.
 

Ampicillin Price Trend for the Q3 of 2024

Ampicillin, a broad-spectrum antibiotic from the penicillin group, is considered an essential medicine in India. It is used to treat respiratory tract, throat, and gastrointestinal infections and is effective against a range of gram-positive and some gram-negative bacteria, including certain strains of E. coli and Salmonella.

The prices of ampicillin remained stable throughout Q3'24, with essential medicine prices generally regulated by government authorities to ensure availability and affordability for the public. Recently, the National Pharmaceutical Pricing Authority (NPPA) set prices for 70 essential medicines, including antibiotics, to make them more affordable, particularly for treating common lifestyle diseases like pain, fever, and infections. In the previous quarter, the prices of 41 commonly used medicines were also fixed.

India is working to reduce its dependency on Chinese active pharmaceutical ingredients (APIs) by encouraging domestic production through a production-linked incentive (PLI) scheme. This has supported increased penicillin production, with new manufacturing units dedicated to antibiotic production. Furthermore, with a focus on boosting domestic pharmaceutical manufacturing, India’s antibiotic exports have gained a significant market share in the United States, as per the latest data from the Ministry of Commerce. This has strengthened market confidence, especially as India competes with inexpensive Chinese products in global markets.

Analyst Insight

According to Procurement Resource, ampicillin prices are expected to remain rangebound in the coming quarter, and no fluctuation is expected due to government restrictions on essential medicines.
 

Ampicillin Price Trend for the Q2 of 2024

Ampicillin prices were confined throughout the given span of Q2’24. The government tried to make essential medicines like ampicillin available for consumers at cheaper prices. The prices of 41 commonly used medicines and six formulations for conditions like cardiovascular diseases, diabetes, and other ailments were reduced. Ampicillin, which is primarily derived from the feedstock antibiotic penicillin, will also see further evolution in the Indian market since the country is restarting the domestic production of penicillin G after nearly 30 years.

The production of Penicillin G in India ceased due to the influx of cheaper subsidized Chinese products and the impact of the Drug Prices Control Order, which favored lower-cost imports. The revival of Penicillin G manufacturing is part of the Production-Linked Incentive (PLI) scheme, designed to boost domestic production of Active Pharmaceutical Ingredients (APIs), drug intermediates, and key starting materials (KSMs). The PLI scheme offers financial incentives over six years to support the production of fermentation-based bulk drugs, including antibiotics, enzymes, and hormones.

Analyst Insight

According to Procurement Resource, Ampicillin prices are expected to remain range-bound in the coming months as well; not much fluctuation is anticipated.
 

Ampicillin Price Trend for the Q1 of 2024

Stay updated with the latest Ampicillin prices, historical data, and tailored regional analysis
 

Not much change was observed in the penicillin prices in the first quarter of 2024 compared to Q4’23. Pharma drug prices in India, especially of the ones on the NLEM (National List of Essential Medicines), are heavily controlled by the Government of India to ensure their affordability and availability to the general masses. Because of this, the prices for medicines on NLEM are generally subsidized. Ampicillin, which is made from the feedstock antibiotic penicillin, is also an important medicine on the list. Hence, only a minimal hike in prices was made.

Still, this hike couldn’t help the pharma companies solve their incurring cost problems as the prices for the feedstock Penicillin G have seen a 175% rise in prices over the past few years. The Pharma sector has been grappling with rising input costs as the manufacturing rates for drugs with feedstocks and other APIs (Active Pharmaceutical Ingredients) keep inclining. To provide some respite, the Government has allowed a minuscule 0.0055% hike in prices for some 800 drugs on NLEM, including Ampicillin.

Analyst Insight

According to Procurement Resource, Ampicillin is about to get a little costlier in the next quarter as authorities have allowed a minimal increase in essential drug prices.
 

Ampicillin Price Trend for the October - December of 2023

Ampicillin market prices observed an inclined trend during the fourth quarter of the year 2023. Ampicillin uses penicillin as its feedstock material, and the unexpectedly high demands of penicillin during the last couple of months raised the prices for its substituent drugs like ampicillin and amoxicillin. Ampicillin is an antibiotic extensively used to aid various infections like those of the respiratory tract, and these infections tend to rise severely during the cold winter months.

This rise in infections caused an upsurge in ampicillin demand during the cold months of the fourth quarter, and this high demand led to a swift increase in ampicillin prices during the given period. Since the drug prices are managed by strict laws and regulations in most countries, the ampicillin prices did not show any abrupt fluctuations; rather, the positive fluctuations in the price trend were also limited within narrow limits. Overall, positive market sentiments were observed.

Analyst Insight

According to Procurement Resource, Ampicillin prices are likely to float upward in the coming quarters as well. Since high demands are driving these market trend, positive market sentiments are expected.
 

Ampicillin Price Trend for the July - September of 2023

Ampicillin is a penicillin-class antibiotic drug widely used to treat various kinds of bacterial infections. Ampicillin price trend continued to escalate in the third quarter of the year 2023 as well, though the rate of escalation subsided somewhat. Initially, it was the increased cost of Chinese raw materials that guided the drug costs in the pharma sector.

However, as the supply chains and freight situations improved, the logistics part of the Ampicillin trade also improved, but the production of raw materials in China slowed over such a long period of disruption. Hence, even though the production is ramping up, the supplies were still constricted with respect to demands during the said period. So, an overall positive market outlook was observed.

Analyst Insight

According to Procurement Resource, future projections look promising for the Ampicillin market trend. With supplies picking up, the pace of inclination may be affected, but the overall market situation will continue to be positive in the near future.
 

Ampicillin Price Trend for the First Half of 2023

The price trend of ampicillin in the first and second quarters inclined steeply as the pharmaceutical industries witnessed a steep spike in the cost of raw materials required for its production. In India, the production of ampicillin is highly dependent on imports from China, and due to the rise in the cost of raw materials, the rates of production in the region have declined.

In addition to this, challenging economic conditions, soaring rates of inflation, and high costs of crude oil, freight charges also played a part in oscillating the price trend of ampicillin. The disruptions in supply chains and logistical challenges in the country due to pandemic-related restrictions and the high cost of energy production exerted a negative impact on the ampicillin price trend. However, despite that, the market was supported by improved sales in pharmaceutical sectors, high demand, and rising cost of production.

Analyst Insight

According to Procurement Resource, the price of Ampicillin is estimated to showcase an upward trajectory as the demand for ampicillin in the domestic and international industries is increasing, and with positive support from the feedstock sector, the price trend of ampicillin is expected to rise.

Procurement Resource provides latest prices of Ampicillin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.